Evaluating HIV vaccines using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support
Funded at University of Louisiana at Lafayette · NIH-10138759 · Data updated 2026-11-12
This study is working on creating better HIV vaccines by testing them in monkeys first, so we can find out how well they work and improve them before they are given to people.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2020 |
| Award (this year) | $270,234 |
| NIH project number | 75N93020D00008-0-759302000001-1 |
| Project ID | NIH-10138759 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are individuals at high risk for HIV infection who may eventually receive effective vaccines developed through this research.
✕Less likely to help
Patients who are already living with HIV or those who do not have access to vaccination programs may not benefit directly from this research.
What this research studies
This research focuses on the development and evaluation of effective HIV vaccines through the use of nonhuman primates (NHPs) in preclinical studies. The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for researchers to assess candidate AIDS vaccines, allowing for thorough evaluations of immune responses and vaccine efficacy. By utilizing NHP models, the research aims to identify correlates of reduced risk of HIV acquisition and enhance the effectiveness of clinical vaccines. The program supports all stages of AIDS vaccine research, from initial evaluations to clinical testing.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent or control HIV infection.
How similar studies have gone: Previous research using nonhuman primates for HIV vaccine evaluation has shown promise, indicating that this approach has the potential for success.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.